CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - New Zealand
Summary
New Zealand is a mature healthcare market with a strong regulatory environment. The largest and fastest growing segment of biologics is monoclonal antibodies, which accounts for around $110m per annum. It spends approximately 11% of its GDP on healthcare. In 2015, the pharmaceutical sales declined to around $688m from around $796m in 2014. This again rose to around $746 in 2016. The market is forecast to grow to and cross $1 billion in 2022; at a CAGR of around 6%. In 2010, the medical device market in New Zealand was worth about $1.17 billion, which increased to around $1.4 billion in 2017. It is expected to grow at a CAGR of about 3.4% from around $1.5 billion in 2018 to $1.8 billion in 2022.
The main segments were ophthalmic devices, wound care management, healthcare IT, orthopedic devices and in vitro diagnostics. The increasing elderly population and high investment in R&D expenditure are expected to drive the growth of pharmaceutical market. However, high penetration of generics in the market and the policies of PHARMAC, pose as a barrier for the multinational pharmaceutical manufacturers
The government of New Zealand encourages innovation and supports biomedical and drug development research with continuous investment in science, research and technology as a mechanism to increase the knowledge economy.
The report CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - New Zealand, provides information on the healthcare, regulatory, and reimbursement landscape in New Zealand, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market (Douglas, Mylan, GSK, Merck and NZP) and profiles and SWOT analyses of the major players in the medical device market (Medtronic, GE Healthcare, DePuy Synthes, Essilor and Fisher & Paykel Healthcare)
- Detailed analysis about recent completed deals in the pharmaceutical and medical device market of New Zealand
- Porter’s five forces analysis for pharmaceutical and medical devices market of New Zealand
- An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
- Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the New Zealand healthcare market
The report provides information on the healthcare, regulatory, and reimbursement landscape in New Zealand, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market (Douglas, Mylan, GSK, Merck and NZP) and profiles and SWOT analyses of the major players in the medical device market (Medtronic, GE Healthcare, DePuy Synthes, Essilor and Fisher & Paykel Healthcare)
- Detailed analysis about recent completed deals in the pharmaceutical and medical device market of New Zealand
- Porter’s five forces analysis for pharmaceutical and medical devices market of New Zealand
- An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
- Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the New Zealand healthcare market.
This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving the New Zealand healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
- Identify, understand, and capitalize on the opportunities and challenges in the New Zealand healthcare market.
- Executive Summary
- Overview of Pharmaceutical Market
- Overview of Medical Device Market
- Deals Analysis
- Porter’s Five Forces Model
- Market Access
- Country Healthcare Landscape
- Opportunities and Challenges
- Appendix
- 1.1 List of Tables
- Table 1: Pharmaceutical Market, New Zealand, Self medication product groups sales ($m), 2016
- Table 2: Pharmaceutical Market, New Zealand, Major therapeutic groups based on sales ($m), 2014
- Table 3: Medical Device Market, New Zealand, Revenue by Segment ($m) and market share (%), 2017
- Table 4: Ophthalmic Devices Market, New Zealand, Revenue ($m) and Market Share (%) of Major Companies, 2015
- Table 5: Wound Care Management Market, New Zealand, Revenue ($m) and Market Share (%) of Major Companies, 2017
- Table 6: Healthcare IT Devices Market, New Zealand, Revenue ($m) and Market Share (%) of Major Companies, 2015
- Table 7: Orthopedic Devices Market, New Zealand, Revenue ($m) and Market Share (%) of Major Companies, 2016
- Table 8: IVD Market, New Zealand, Revenue ($m) and Market Share (%) of Major Companies, 2017
- Table 9: NMA Fees, New Zealand, 2017
- Table 10: Patent Fees, New Zealand, 2017
- Table 11: Trademark Fees, New Zealand, 2017
- Table 12: Clinical Trial Application Fees, New Zealand, 2015
- Table 13: Pharmacy Regulations, New Zealand, 2011
- Table 14: Labeling and Packaging Regulations, New Zealand, 2018
- Table 15: Trade Fairs, New Zealand
- 1.2 List of Figures
- Figure 1: Pharmaceutical Market, New Zealand, Revenue ($m), 2010-2017
- Figure 2: Medical Device Market, New Zealand, Revenue ($bn), 2010-2017
- Figure 3: Country Profile, New Zealand, 2018
- Figure 4: Pharmaceutical Market, New Zealand, Revenue ($m), 2010-2017
- Figure 5: Pharmaceutical Market, New Zealand, Revenue Forecast ($m), 2018-2022
- Figure 6: Pharmaceutical Exports ($m), New Zealand, 2010-2017
- Figure 7: Top Export Partners, New Zealand, 2016
- Figure 8: Pharmaceutical Imports ($m), New Zealand, 2010-2017
- Figure 9: Top Import Partners, New Zealand, 2016
- Figure 10: Distribution Channels, New Zealand, 2016
- Figure 11: Pharmaceutical Market, New Zealand, Major therapeutic groups based on sales ($m), 2014
- Figure 12: Pharmaceutical Market, New Zealand, Major Players
- Figure 13: Medical Device Market, New Zealand, Revenue ($bn), 2010-2017
- Figure 14: Medical Device Market, New Zealand, Revenue Forecast ($bn), 2018-2022
- Figure 15: Medical Device Market, New Zealand, Revenue by Segment ($m), 2017
- Figure 16: Ophthalmic Devices Market, New Zealand, Revenue ($m), 2010-2017
- Figure 17: Ophthalmic Devices Market, New Zealand, Market Share of Major Players (%), 2015
- Figure 18: Wound Care Management Market, New Zealand, Revenue ($m), 2010-2017
- Figure 19: Wound Care Management Market, New Zealand, Market Share of Major Players (%), 2017
- Figure 20: Healthcare IT Devices Market, New Zealand, Revenue ($m), 2010-2017
- Figure 21: Healthcare IT Devices Market, New Zealand, Market Share of Major Players (%), 2015
- Figure 22: Orthopedic Devices Market, New Zealand, Revenue ($m), 2010-2017
- Figure 23: Orthopedic Devices Market, New Zealand, Market Share of Major Players (%), 2016
- Figure 24: IVD Market, New Zealand, Revenue ($m), 2010-2017
- Figure 25: IVD Market, New Zealand, Market Share of Major Companies (%), 2017
- Figure 26: Diagnostic Market, New Zealand, Revenue ($bn), 2010-2017
- Figure 27: Diagnostic Market, New Zealand, Revenue ($bn), 2018-2022
- Figure 28: Medical Device Market, New Zealand, Revenue ($bn) of Major Companies, 2016
- Figure 29: Deal Value and Deal Count, Pharmaceutical Market, New Zealand, 2017-2018
- Figure 30: Deal Value and Deal Count Quarterly, Pharmaceutical Market, New Zealand, 2017-2018
- Figure 31:Deal Value and Deal Count Sub-Types, Pharmaceutical Market, New Zealand, 2017-2018
- Figure 32: Top 5 therapy area by deal value, Pharmaceutical Market, New Zealand, 2017-2018
- Figure 33: Top 5 therapy area by deal number, Pharmaceutical Market, New Zealand, 2017-2018
- Figure 34: M&A deals by therapy area, Pharmaceutical Market, New Zealand, 2017-2018 (By value and by number)
- Figure 35: Venture Financing deals by therapy area, Pharmaceutical Market, New Zealand, 2017-2018 (By value and by number)
- Figure 36: Private Equity deals by therapy area, Pharmaceutical Market New Zealand, 2017-2018 (By value and by number)
- Figure 37: Overview of Healthcare System, New Zealand, 2015
- Figure 38: Drug Funding/Reimbursement Approval Process , New Zealand, 2013
- Figure 39: Out-of-Pocket Expenditure (% of total expenditure on health), New Zealand, 2010-2017
- Figure 40: Change in Health CPI(%), New Zealand , 2009-2016
- Figure 41: Process of Drug Funding, New Zealand
- Figure 42: MEDSAFE, Organizational structure, New Zealand, 2015
- Figure 43: Market Authorization Procedure, New Zealand, 2015
- Figure 44: WAND Process, New Zealand
- Figure 45: Licensing Process for Pharmaceutical Manufacturing, New Zealand
- Figure 46: Patent Approval Process, New Zealand, 2017
- Figure 47: Trademark Approval Process, New Zealand, 2017
- Figure 48: Clinical Trial Regulation Process, New Zealand, 2015
- Figure 49: Pharmaceutical Advertisement Approval Process, New Zealand, 2011
- Figure 50: Hospitals (Number), New Zealand, 2010-2017
- Figure 51: Public - Private Hospitals (Number), New Zealand, 2010-2017
- Figure 52: Diagnostic Equipment (Number), New Zealand, 2010-2017
- Figure 53: Hospital Beds (per 1,000 population), New Zealand, 2010 - 2017
- Figure 54: Life Expectancy (years), New Zealand, 2010-2017
- Figure 55: Immunization Rate (%), New Zealand, 2010-2017
- Figure 56: Major Causes of Mortality, No. of deaths (‘000), New Zealand, 2012
- Figure 57: Major Causes of Male Mortality, No. of deaths (‘000), New Zealand, 2015
- Figure 58: Major Causes of Female Mortality, No. of deaths (‘000), New Zealand, 2015
- Figure 59: Disability-Adjusted Life Years by Major Disease (‘000), New Zealand, 2015
- Figure 60: Physicians (per 1,000 population), New Zealand, 2010-2017
- Figure 61: Dentists, (per 1,000 population), New Zealand, 2010-2017
- Figure 62: Nurses (per 1,000 population), New Zealand, 2010-2017
- Figure 63: Pharmacists, (per 1,000 population), New Zealand, 2010-2017
- Figure 64: PM2.5 (μg per m3), New Zealand, 2010-2017
- Figure 65: CO2 Emissions (k tons), New Zealand, 2010-2017
- Figure 66: Healthcare Expenditure (% of GDP ), New Zealand, 2010-2017
- Figure 67: Public-Private Share (%), New Zealand, 2010-2017
- Figure 68: Major Components of Healthcare Spending (%), New Zealand, 2011
- Figure 69: Spending in R&D by sector ($m) , New Zealand, 2008-2016
- Figure 70: Opportunities and Challenges
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook